Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Amirhossein Sahebkar and Matteo Pirro.
Amirhossein Sahebkar
Connection Strength
12.235
Matteo Pirro
  1. Effect of Statin Therapy on Arterial Wall Inflammation Based on 18F-FDG PET/CT: A Systematic Review and Meta-Analysis of Interventional Studies. J Clin Med. 2019 Jan 18; 8(1).
    View in: PubMed
    Score: 0.805
  2. Statistical vs clinical significance: A matter of debate for orlistat treatment. Pharmacol Res. 2017 Oct; 124:158-159.
    View in: PubMed
    Score: 0.722
  3. Effect of orlistat on plasma lipids and body weight: A systematic review and meta-analysis of 33 randomized controlled trials. Pharmacol Res. 2017 Aug; 122:53-65.
    View in: PubMed
    Score: 0.718
  4. Lipoprotein(a) and inflammation: A dangerous duet leading to endothelial loss of integrity. Pharmacol Res. 2017 05; 119:178-187.
    View in: PubMed
    Score: 0.703
  5. Prevalence of vitamin D deficiency and its prognostic impact on patients hospitalized with COVID-19. Nutrition. 2021 Nov-Dec; 91-92:111408.
    View in: PubMed
    Score: 0.238
  6. Commentary: Statins, COVID-19, and coronary artery disease: killing two birds with one stone. Metabolism. 2020 12; 113:154375.
    View in: PubMed
    Score: 0.226
  7. Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ? Drugs. 2020 Sep; 80(14):1383-1396.
    View in: PubMed
    Score: 0.225
  8. Interaction Between Coronavirus S-Protein and Human ACE2: Hints for Exploring Efficient Therapeutic Targets to Treat COVID-19. Angiology. 2021 02; 72(2):122-130.
    View in: PubMed
    Score: 0.225
  9. Particulate matter pollution and the COVID-19 outbreak: results from Italian regions and provinces. Arch Med Sci. 2020; 16(5):985-992.
    View in: PubMed
    Score: 0.220
  10. Statins and the COVID-19 main protease: in silico evidence on direct interaction. Arch Med Sci. 2020; 16(3):490-496.
    View in: PubMed
    Score: 0.220
  11. PCSK9 and inflammation: a review of experimental and clinical evidence. Eur Heart J Cardiovasc Pharmacother. 2019 10 01; 5(4):237-245.
    View in: PubMed
    Score: 0.211
  12. Challenges and pitfalls in the development of liposomal delivery systems for cancer therapy. Semin Cancer Biol. 2021 02; 69:337-348.
    View in: PubMed
    Score: 0.211
  13. Regulation of cardiac stem cells by microRNAs: State-of-the-art. Biomed Pharmacother. 2019 Dec; 120:109447.
    View in: PubMed
    Score: 0.211
  14. The Role of Mesenchymal Stem Cells in Atherosclerosis: Prospects for Therapy via the Modulation of Inflammatory Milieu. J Clin Med. 2019 Sep 08; 8(9).
    View in: PubMed
    Score: 0.210
  15. Modulation of regulatory T cells by natural products in cancer. Cancer Lett. 2019 09 10; 459:72-85.
    View in: PubMed
    Score: 0.207
  16. Mast cell tryptase - Marker and maker of cardiovascular diseases. Pharmacol Ther. 2019 07; 199:91-110.
    View in: PubMed
    Score: 0.203
  17. Dietary natural products as emerging lipoprotein(a)-lowering agents. J Cell Physiol. 2019 08; 234(8):12581-12594.
    View in: PubMed
    Score: 0.201
  18. A review of the anti-inflammatory properties of antidiabetic agents providing protective effects against vascular complications in diabetes. J Cell Physiol. 2019 06; 234(6):8286-8294.
    View in: PubMed
    Score: 0.199
  19. Effect of omega-3 supplements on plasma apolipoprotein C-III concentrations: a systematic review and meta-analysis of randomized controlled trials. Ann Med. 2018 11; 50(7):565-575.
    View in: PubMed
    Score: 0.197
  20. Impact of fibrates on circulating cystatin C levels: a systematic review and meta-analysis of clinical trials. Ann Med. 2018 09; 50(6):485-493.
    View in: PubMed
    Score: 0.196
  21. The Role of Efferocytosis in Autoimmune Diseases. Front Immunol. 2018; 9:1645.
    View in: PubMed
    Score: 0.194
  22. High density lipoprotein cholesterol and cancer: Marker or causative? Prog Lipid Res. 2018 07; 71:54-69.
    View in: PubMed
    Score: 0.193
  23. PCSK9 and neurocognitive function: Should it be still an issue after FOURIER and EBBINGHAUS results? J Clin Lipidol. 2018 Sep - Oct; 12(5):1123-1132.
    View in: PubMed
    Score: 0.193
  24. Cholesterol-Lowering Nutraceuticals Affecting Vascular Function and Cardiovascular Disease Risk. Curr Cardiol Rep. 2018 05 25; 20(7):53.
    View in: PubMed
    Score: 0.192
  25. MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia? Clin Rev Allergy Immunol. 2018 Apr; 54(2):224-233.
    View in: PubMed
    Score: 0.190
  26. Elevated serum uric acid levels are associated with endothelial dysfunction in HIV patients receiving highly-active antiretroviral therapy. Atherosclerosis. 2018 05; 272:101-107.
    View in: PubMed
    Score: 0.190
  27. Oxidative burden in familial hypercholesterolemia. J Cell Physiol. 2018 08; 233(8):5716-5725.
    View in: PubMed
    Score: 0.189
  28. Effect of statin therapy on plasma apolipoprotein CIII concentrations: A systematic review and meta-analysis of randomized controlled trials. J Clin Lipidol. 2018 May - Jun; 12(3):801-809.
    View in: PubMed
    Score: 0.188
  29. Improvement of endothelial function by pitavastatin: a meta-analysis. Expert Opin Pharmacother. 2018 Feb; 19(3):279-286.
    View in: PubMed
    Score: 0.188
  30. The regulation and importance of monocyte chemoattractant protein-1. Curr Opin Hematol. 2018 Jan; 25(1):44-51.
    View in: PubMed
    Score: 0.187
  31. Effect of Metformin on Plasma Fibrinogen Concentrations: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials. Curr Pharm Des. 2018; 24(9):1034-1040.
    View in: PubMed
    Score: 0.187
  32. Effects of Allopurinol on Endothelial Function: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials. Drugs. 2018 Jan; 78(1):99-109.
    View in: PubMed
    Score: 0.187
  33. Curcumin as an Adjunct Therapy and microRNA Modulator in Breast Cancer. Curr Pharm Des. 2018; 24(2):171-177.
    View in: PubMed
    Score: 0.187
  34. Emerging enzymatic targets controlling angiogenesis in cancer: preclinical evidence and potential clinical applications. Med Oncol. 2017 Dec 04; 35(1):4.
    View in: PubMed
    Score: 0.186
  35. Lipid-modifying activity of curcuminoids: A systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2019; 59(7):1178-1187.
    View in: PubMed
    Score: 0.186
  36. Enzymes involved in tumor-driven angiogenesis: A valuable target for anticancer therapy. Semin Cancer Biol. 2019 06; 56:87-99.
    View in: PubMed
    Score: 0.185
  37. HDL functionality in type 1 diabetes. Atherosclerosis. 2017 Dec; 267:99-109.
    View in: PubMed
    Score: 0.185
  38. Effect of soy isoflavone supplementation on plasma lipoprotein(a) concentrations: A meta-analysis. J Clin Lipidol. 2018 Jan - Feb; 12(1):16-24.
    View in: PubMed
    Score: 0.184
  39. Immune modulation by curcumin: The role of interleukin-10. Crit Rev Food Sci Nutr. 2019; 59(1):89-101.
    View in: PubMed
    Score: 0.183
  40. Lipid-lowering activity of artichoke extracts: A systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2018; 58(15):2549-2556.
    View in: PubMed
    Score: 0.183
  41. Endothelial and cardiac progenitor cells for cardiovascular repair: A controversial paradigm in cell therapy. Pharmacol Ther. 2018 01; 181:156-168.
    View in: PubMed
    Score: 0.182
  42. Hepatitis C virus and proprotein convertase subtilisin/kexin type 9: a detrimental interaction to increase viral infectivity and disrupt lipid metabolism. J Cell Mol Med. 2017 Dec; 21(12):3150-3161.
    View in: PubMed
    Score: 0.181
  43. Lipoprotein(a): A missing culprit in the management of athero-thrombosis? J Cell Physiol. 2018 04; 233(4):2966-2981.
    View in: PubMed
    Score: 0.181
  44. Statins, haemostatic factors and thrombotic risk. Curr Opin Cardiol. 2017 Jul; 32(4):460-466.
    View in: PubMed
    Score: 0.181
  45. Regulatory effects of berberine on microRNome in Cancer and other conditions. Crit Rev Oncol Hematol. 2017 Aug; 116:147-158.
    View in: PubMed
    Score: 0.180
  46. Effect of dipeptidyl peptidase-4 inhibitors on circulating tumor necrosis factor-a concentrations: A systematic review and meta-analysis of controlled trials. J Diabetes Complications. 2017 Sep; 31(9):1458-1464.
    View in: PubMed
    Score: 0.180
  47. Regulation of PCSK9 by nutraceuticals. Pharmacol Res. 2017 Jun; 120:157-169.
    View in: PubMed
    Score: 0.178
  48. Effects of curcumin on HDL functionality. Pharmacol Res. 2017 05; 119:208-218.
    View in: PubMed
    Score: 0.176
  49. PCSK9 at the crossroad of cholesterol metabolism and immune function during infections. J Cell Physiol. 2017 Sep; 232(9):2330-2338.
    View in: PubMed
    Score: 0.176
  50. PCSK9 and diabetes: is there a link? Drug Discov Today. 2017 06; 22(6):883-895.
    View in: PubMed
    Score: 0.175
  51. Curcumin and Endothelial Function: Evidence and Mechanisms of Protective Effects. Curr Pharm Des. 2017; 23(17):2462-2473.
    View in: PubMed
    Score: 0.175
  52. Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases - A position paper from the International Lipid Expert Panel (ILEP). Prog Cardiovasc Dis. 2021 Jul-Aug; 67:40-52.
    View in: PubMed
    Score: 0.060
  53. Cholesterol in Relation to COVID-19: Should We Care about It? J Clin Med. 2020 Jun 18; 9(6).
    View in: PubMed
    Score: 0.055
  54. S1P promotes migration, differentiation and immune regulatory activity in amniotic-fluid-derived stem cells. Eur J Pharmacol. 2018 Aug 15; 833:173-182.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.